Finding 26320 (2022-004)

Significant Deficiency Repeat Finding
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2023-09-28

AI Summary

  • Issue: The final SF-425 was submitted late for the period ending December 31, 2022.
  • Requirement: Timely submission of the SF-425 is mandated by the OMB compliance supplement and HRSA compliance manual.
  • Follow-up: Ensure future submissions meet deadlines to avoid compliance issues.

Finding Text

As per the OMB compliance supplement and the HRSA compliance manual, the Organization must submit the final SF-425 within the due date. During our audit, we noted that the final SF-425 for the period ended December 31, 2022 was submitted after the due date.

Categories

Reporting

Other Findings in this Audit

  • 26314 2022-003
    Significant Deficiency Repeat
  • 26315 2022-004
    Significant Deficiency Repeat
  • 26316 2022-005
    Significant Deficiency Repeat
  • 26317 2022-006
    Material Weakness Repeat
  • 26318 2022-006
    Material Weakness Repeat
  • 26319 2022-003
    Significant Deficiency Repeat
  • 26321 2022-005
    Significant Deficiency Repeat
  • 26322 2022-006
    Material Weakness Repeat
  • 26323 2022-003
    Significant Deficiency Repeat
  • 26324 2022-004
    Significant Deficiency Repeat
  • 26325 2022-005
    Significant Deficiency Repeat
  • 26326 2022-006
    Material Weakness Repeat
  • 26327 2022-006
    Material Weakness Repeat
  • 26328 2022-006
    Material Weakness Repeat
  • 602756 2022-003
    Significant Deficiency Repeat
  • 602757 2022-004
    Significant Deficiency Repeat
  • 602758 2022-005
    Significant Deficiency Repeat
  • 602759 2022-006
    Material Weakness Repeat
  • 602760 2022-006
    Material Weakness Repeat
  • 602761 2022-003
    Significant Deficiency Repeat
  • 602762 2022-004
    Significant Deficiency Repeat
  • 602763 2022-005
    Significant Deficiency Repeat
  • 602764 2022-006
    Material Weakness Repeat
  • 602765 2022-003
    Significant Deficiency Repeat
  • 602766 2022-004
    Significant Deficiency Repeat
  • 602767 2022-005
    Significant Deficiency Repeat
  • 602768 2022-006
    Material Weakness Repeat
  • 602769 2022-006
    Material Weakness Repeat
  • 602770 2022-006
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.526 Affordable Care Act (aca) Grants for Capital Development in Health Centers $744,398
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $163,041
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $53,465
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $24,408